Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis Chantal Lagresle-Peyrou, PhD, Bénédicte Neven, MD, Emmanuelle Six, PhD, Capucine Picard, MD, PhD, Corinne Demerens-de Chappedelaine, PhD, Yves Bertrand, MD, PhD, Nada Jabado, MD, Christine Chomienne, MD, PhD, Isabelle Radford-Weiss, MD, Chantal Brouzes, MD, Vahid Asnafi, MD, PhD, Elizabeth MacIntyre, MD, PhD, Jean Donadieu, MD, PhD, Blandine Beaupain, PhD, Pierre Fenaux, MD, PhD, Virginie Eclache, MD, Alain Fischer, MD, PhD, Marina Cavazzana-Calvo, MD, PhD Journal of Allergy and Clinical Immunology Volume 128, Issue 1, Pages 230-232.e2 (July 2011) DOI: 10.1016/j.jaci.2011.02.008 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Blood cell counts from patient 1 after HSCT Blood cell counts from patient 1 after HSCT. Leukocyte and lymphocyte counts (A) and absolute neutrophil counts (ANC; B) are represented at various time points after HSCT. HSCT 1, First HSCT; HSCT 2, second HSCT. ∗Initiation of G-CSF treatment; ✦detection of blast cells. Journal of Allergy and Clinical Immunology 2011 128, 230-232.e2DOI: (10.1016/j.jaci.2011.02.008) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Blood cell counts from patient 2 after HSCT Blood cell counts from patient 2 after HSCT. Leukocyte and lymphocyte number (A) and absolute neutrophil count (ANC; B) are represented at various time points after HSCT. HSCT 1, First HSCT; HSCT 2, second HSCT. ∗Initiation of G-CSF treatment; ✦detection of blast cells. Journal of Allergy and Clinical Immunology 2011 128, 230-232.e2DOI: (10.1016/j.jaci.2011.02.008) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions